Exploring the burgeoning role of non-viral approaches in the delivery of nucleic acids

Cell & Gene Therapy Insights 2023; 9(11), 1547–1552

DOI: 10.18609/cgti.2023.203

Published: 5 January
Zhenghong Gao

David McCall, Senior Editor at Cell & Gene Therapy Insights, engages in a conversation with Zhenghong Gao, Director, Head of Nonviral Delivery at Asklepios BioPharmaceutical, Inc. (AskBio), exploring the increasing prominence of non-viral delivery in genomic medicine. The discussion delves into the intricacies of incorporating lipid nanoparticles in therapeutic contexts and sheds light on the promises, complexities, and key considerations associated with DNA and RNA payloads.